Replies to post #3130 on Spectrum Pharmaceutecals Inc (SPPI)

[carusso]

Or did a competitor influence this?

[antihama]

Not sure I’m completely following you but if they are pointing out

They state that the chemotherapy/checkpoint "subgroup" of 59 patients had an ORR of 25% and that the ORR of the entire Cohort study was ~28%

Shouldn’t they note that the “subgroup” of 31 patients who didn’t have Chemo/CI would have an ORR of greater than 30%. IMO, pozi should get AA. It seems like they have different standards for more influential Big Pharma than they do for the little guys..